Donna R. Cryer, JD, is president and chief executive officer of the Global Liver Institute, the innovation and collaboration platform for liver health worldwide. An attorney and award-winning patient advocate, she is an entrepreneurial business executive with expertise in digital health, precision medicine, drug development, and health policy.
For more than a decade, Mrs. Cryer led CryerHealth, a healthcare consulting firm she founded, providing strategic counsel to top biopharmaceutical companies, patient advocacy organizations, and emerging technology firms on patient engagement in health information technology, drug discovery, and clinical decision-making.
Mrs. Cryer serves on the executive committees of the People Centered Research Foundation and the Clinical Trials Transformation Initiative, as well as on the executive advisory board for Tivity Health.
She has been named one of the “Top Blacks in Healthcare” by the Milken Institute at GW School of Public Health and BlackDoctor.org, one of the “Top 10 Patients Who Make an Impact” by Health 2.0, and one of PharmaVoice’s “100 Most Inspiring People.”